Our analysis not only demonstrated an increased percentage of dendritic cells but, importantly, a reduced proportion of immunosuppressive iNOS-producing dendritic cells within the tumor environment of metformin-treated mice (Figure 5I,J). The gene discussed is NOS2; the disease is neoplasm.